Logo image of BW

BABCOCK & WILCOX ENTERPR (BW) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BW - US05614L2097 - Common Stock

8.31 USD
+0.09 (+1.09%)
Last: 1/15/2026, 8:04:00 PM
8.38 USD
+0.07 (+0.84%)
Pre-Market: 1/16/2026, 8:41:42 AM
Fundamental Rating

2

BW gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 91 industry peers in the Electrical Equipment industry. BW may be in some trouble as it scores bad on both profitability and health. BW does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year BW has reported negative net income.
  • BW had a negative operating cash flow in the past year.
  • BW had negative earnings in 4 of the past 5 years.
  • BW had a negative operating cash flow in each of the past 5 years.
BW Yearly Net Income VS EBIT VS OCF VS FCFBW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

  • BW has a Return On Assets (-18.78%) which is in line with its industry peers.
  • BW's Return On Invested Capital of 11.77% is amongst the best of the industry. BW outperforms 89.01% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BW is significantly below the industry average of 9.92%.
  • The 3 year average ROIC (3.67%) for BW is below the current ROIC(11.77%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -18.78%
ROE N/A
ROIC 11.77%
ROA(3y)-13.87%
ROA(5y)-8.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.67%
ROIC(5y)3.7%
BW Yearly ROA, ROE, ROICBW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

  • With a decent Operating Margin value of 7.08%, BW is doing good in the industry, outperforming 73.63% of the companies in the same industry.
  • BW's Operating Margin has improved in the last couple of years.
  • BW has a Gross Margin of 26.77%. This is comparable to the rest of the industry: BW outperforms 56.04% of its industry peers.
  • In the last couple of years the Gross Margin of BW has grown nicely.
Industry RankSector Rank
OM 7.08%
PM (TTM) N/A
GM 26.77%
OM growth 3Y9.27%
OM growth 5Y41.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.18%
GM growth 5Y5.75%
BW Yearly Profit, Operating, Gross MarginsBW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BW is still creating some value.
  • The number of shares outstanding for BW has been increased compared to 1 year ago.
  • The number of shares outstanding for BW has been increased compared to 5 years ago.
  • Compared to 1 year ago, BW has a worse debt to assets ratio.
BW Yearly Shares OutstandingBW Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BW Yearly Total Debt VS Total AssetsBW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of -1.84, we must say that BW is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -1.84, BW is not doing good in the industry: 67.03% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.84
ROIC/WACC1.47
WACC8.02%
BW Yearly LT Debt VS Equity VS FCFBW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

  • BW has a Current Ratio of 1.20. This is a normal value and indicates that BW is financially healthy and should not expect problems in meeting its short term obligations.
  • BW's Current ratio of 1.20 is on the low side compared to the rest of the industry. BW is outperformed by 65.93% of its industry peers.
  • BW has a Quick Ratio of 1.04. This is a normal value and indicates that BW is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.04, BW perfoms like the industry average, outperforming 48.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.04
BW Yearly Current Assets VS Current LiabilitesBW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1

3. Growth

3.1 Past

  • BW shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.68%.
  • BW shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -38.45%.
  • Measured over the past years, BW shows a decrease in Revenue. The Revenue has been decreasing by -3.54% on average per year.
EPS 1Y (TTM)-3.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3344.44%
Revenue 1Y (TTM)-38.45%
Revenue growth 3Y-0.28%
Revenue growth 5Y-3.54%
Sales Q2Q%-29.01%

3.2 Future

  • Based on estimates for the next years, BW will show a very strong growth in Earnings Per Share. The EPS will grow by 28.73% on average per year.
  • BW is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.06% yearly.
EPS Next Y47.59%
EPS Next 2Y40.86%
EPS Next 3Y28.73%
EPS Next 5YN/A
Revenue Next Year-28.12%
Revenue Next 2Y-13.19%
Revenue Next 3Y-4.06%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BW Yearly Revenue VS EstimatesBW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
BW Yearly EPS VS EstimatesBW Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -20 -40

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BW. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BW. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BW Price Earnings VS Forward Price EarningsBW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BW is valued a bit cheaper than the industry average as 72.53% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.92
BW Per share dataBW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • BW's earnings are expected to grow with 28.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.86%
EPS Next 3Y28.73%

0

5. Dividend

5.1 Amount

  • BW does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BABCOCK & WILCOX ENTERPR

NYSE:BW (1/15/2026, 8:04:00 PM)

Premarket: 8.38 +0.07 (+0.84%)

8.31

+0.09 (+1.09%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-04
Earnings (Next)03-30
Inst Owners69.32%
Inst Owner Change0.04%
Ins Owners3.06%
Ins Owner Change6.06%
Market Cap923.24M
Revenue(TTM)540.53M
Net Income(TTM)-123.55M
Analysts81.82
Price Target8.5 (2.29%)
Short Float %2.3%
Short Ratio0.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.2
Dividend Growth(5Y)N/A
DP-12.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-66.18%
Min EPS beat(2)-579.61%
Max EPS beat(2)447.26%
EPS beat(4)2
Avg EPS beat(4)-1223.08%
Min EPS beat(4)-4779.86%
Max EPS beat(4)447.26%
EPS beat(8)3
Avg EPS beat(8)-1249.61%
EPS beat(12)3
Avg EPS beat(12)-899.66%
EPS beat(16)4
Avg EPS beat(16)-690.07%
Revenue beat(2)0
Avg Revenue beat(2)-13.31%
Min Revenue beat(2)-19.61%
Max Revenue beat(2)-7.01%
Revenue beat(4)1
Avg Revenue beat(4)-6.73%
Min Revenue beat(4)-19.61%
Max Revenue beat(4)8.19%
Revenue beat(8)1
Avg Revenue beat(8)-7.44%
Revenue beat(12)4
Avg Revenue beat(12)-2.82%
Revenue beat(16)6
Avg Revenue beat(16)-2.21%
PT rev (1m)0%
PT rev (3m)212.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1201.2%
EPS NY rev (1m)0%
EPS NY rev (3m)40.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.68%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.71
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 27.92
EPS(TTM)-1.1
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.92
FCFYN/A
OCF(TTM)-0.8
OCFYN/A
SpS4.87
BVpS-2.09
TBVpS-2.71
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -18.78%
ROE N/A
ROCE 14.9%
ROIC 11.77%
ROICexc 11.77%
ROICexgc 16.12%
OM 7.08%
PM (TTM) N/A
GM 26.77%
FCFM N/A
ROA(3y)-13.87%
ROA(5y)-8.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.67%
ROIC(5y)3.7%
ROICexc(3y)4.08%
ROICexc(5y)4.44%
ROICexgc(3y)6%
ROICexgc(5y)6.49%
ROCE(3y)4.64%
ROCE(5y)4.69%
ROICexgc growth 3Y18.44%
ROICexgc growth 5Y33.31%
ROICexc growth 3Y21.33%
ROICexc growth 5Y31.59%
OM growth 3Y9.27%
OM growth 5Y41.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.18%
GM growth 5Y5.75%
F-Score3
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 5.61
Cap/Depr 126.41%
Cap/Sales 2.51%
Interest Coverage 1.13
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.2
Quick Ratio 1.04
Altman-Z -1.84
F-Score3
WACC8.02%
ROIC/WACC1.47
Cap/Depr(3y)56.25%
Cap/Depr(5y)50.83%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3344.44%
EPS Next Y47.59%
EPS Next 2Y40.86%
EPS Next 3Y28.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-38.45%
Revenue growth 3Y-0.28%
Revenue growth 5Y-3.54%
Sales Q2Q%-29.01%
Revenue Next Year-28.12%
Revenue Next 2Y-13.19%
Revenue Next 3Y-4.06%
Revenue Next 5YN/A
EBIT growth 1Y142.35%
EBIT growth 3Y8.96%
EBIT growth 5Y36.41%
EBIT Next Year-3.6%
EBIT Next 3Y12.38%
EBIT Next 5YN/A
FCF growth 1Y-259.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-550.19%
OCF growth 3YN/A
OCF growth 5YN/A

BABCOCK & WILCOX ENTERPR / BW FAQ

What is the ChartMill fundamental rating of BABCOCK & WILCOX ENTERPR (BW) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BW.


What is the valuation status of BABCOCK & WILCOX ENTERPR (BW) stock?

ChartMill assigns a valuation rating of 1 / 10 to BABCOCK & WILCOX ENTERPR (BW). This can be considered as Overvalued.


What is the profitability of BW stock?

BABCOCK & WILCOX ENTERPR (BW) has a profitability rating of 3 / 10.


How financially healthy is BABCOCK & WILCOX ENTERPR?

The financial health rating of BABCOCK & WILCOX ENTERPR (BW) is 1 / 10.


Is the dividend of BABCOCK & WILCOX ENTERPR sustainable?

The dividend rating of BABCOCK & WILCOX ENTERPR (BW) is 0 / 10 and the dividend payout ratio is -12.26%.